Verona Pharma (LON:VRP)

Verona Pharma (LON:VRP)


Share Price
58.50 p
Change
0 (0.00 %)
Market Cap
£61.62 m
Proactive Investors - Run By Investors For Investors

Verona Pharma

www.veronapharma.com

Overview

Figures in £(m) unless stated
Sales -
EBITDA -25.502
Operating Profit -25.600
Pre-tax Profit -24.133
Net Profit -19.901
Capex -0.268
Operating Cash Flow -18.111
Net Working Capital 61.440
Key Ratios
EBITDA Margin 0.000
Operating Profit Margin 0.000 -%
Net Profit Margin 0.000 -%
Capex/Sales (%) 0.000
NWC/Sales (%) -
Asset Turnover 0.000
Days Inventory 0.000  days
Days Receivable 0.000  days
Days Payable 0.000  days
Performance (Last 3 Years)
Sales CAGR 0.000
EBITDA CAGR n/a
Operating Profit CAGR -
Profit CAGR -
Return on Equity(%) -27.870
Return on Assets(%) -24.304
Return on Invested Capital (ROIC)(%) -28.864
ROIC - WACC n/a
Valuation
Market Cap -
Price to Earnings 0.000
Price to Book Value 1.060
Price to Tangible Book -
Equity to FCF Yield -264.65227817746
Enterprise Value -
EV to Sales -
EV to EBITDA -
EV to Operating Profit -
EV to Invested Capital -
EV to FCF Yield -
Dividend Yield -
Payout Ratio 0
Per Share Data (in GBp unless stated)
Earnings per share -0.189000
Operating Cashflow per share -0.17230437787645
Free Cashflow per share -0.208500
Dividend per share -
NAV per share -
Cash per share -0.206700
Solvency
Intangibles Incl. Excl.
Net debt to Equity % -31.436107668351 -32.777216322338
Cash to Equity % 31.436107668351 -257499968.56389
Gross debt to Equity % 0 0
Gross Debt < 1 Year to Equity - -
Net debt to Assets % 0 0
Net Debt/EBITDA 77.578229158497 -0
Net Interest Cover n/a
Op Cashflow Interest Cover -INF n/a
Current Ratio 7.008802 n/a
Quick Ratio 6.435599 n/a
Cash Ratio - n/a (Intangibles collected as non-current)
Dividend Cover - n/a
Key Dates
Latest Dividend Pay date n/a
Latest Ex-Dividend date n/a
Last Annual Results 2019-03-19
Last Interim Results 2019-03-19

Profit/Loss

Figures in £(m) unless stated31/12/1831/12/1731/12/1631/12/1531/12/1431/12/1331/12/1231/12/11
Sales -0.0000.0000.0000.0000.0000.000-
Cost of Goods Sold ----0.0000.0000.000-
Gross Profit ----0.0000.0000.000-
Operating Expenses 25.60029.7206.8788.9713.7932.8172.5851.840
EBITDA -25.502-29.597-6.817-8.918-3.740-2.779-2.555-1.816
Depreciation & Amortisation --------
EBIT (Operating Profit) -25.600-29.720-6.878-8.971-3.793-2.817-2.585-1.840
Interest Expense/Income --------
Profit Before Tax -24.133-25.203-5.973-8.926-3.763-2.814-2.565-1.844
Taxes on Income -4.232-4.706-0.954-1.509-1.004-0.289-0.048-0.124
Net Profit -19.901-20.497-5.018-7.417-2.759-2.525-2.517-1.720
Net Margin --------
Net profit/loss per share
Basic EPS -0.189-0.234-0.150-0.365-0.160-0.370-0.410-0.350
Diluted EPS -0.189-0.234-0.150-0.365-0.160-0.370-0.410-0.350

Balance sheet

 
Figures in £(m) unless stated 31/12/1831/12/1731/12/1631/12/1531/12/1431/12/1331/12/1231/12/11
ASSETS         
Tangible Assets --------
Intangible Assets 2.5752.4102.3181.8131.8501.6761.5941.584
Investments --------
Total Fixed Assets 2.5962.4262.3321.8271.8711.7041.6341.590
Stocks --------
Debtors -------0.046
Cash & Equivalents --------
Total Current Assets 71.66587.07843.8115.57211.2570.8531.1692.617
Other Assets n/a         
Total Assets 74.26189.50446.1437.39913.1292.5572.8034.207
LIABILITIES         
Interest bearing debt < 1 year
Other Trade Creditors < 1 year --------
Total Creditors within 1 year 10.2258.59610.8721.8130.5240.4890.1990.156
Interest bearing debt > 1 year --------
Other Trade Creditors > 1 year --------
Total Creditors > 1 year 0.0000.0000.0000.0000.0000.0000.0000.000
Other Liabilities  n/a         
Total Liabilities 11.3279.62311.6741.8130.5240.4890.1990.156
Net Assets(NET Tangible Assets exist) 60.35977.47132.1513.77410.7550.3921.0092.467
EQUITY         
Called up share capital 5.2665.2512.5681.0101.0100.3730.3070.286
Share Premium 118.862118.86258.52726.65026.65014.18412.44711.466
Profit / loss -69.117-49.254-28.728-23.096-15.733-13.130-10.622-8.211
Other Equity 7.9235.0222.1021.0220.6780.6410.4710.510
Shareholders Funds 62.93479.88134.4685.58712.6042.0682.6034.051
Preference Stock --------
Total Capital Employed 62.93479.88134.4685.58712.6042.0682.6034.051

Cash flow

Figures in £(m) unless stated 31/12/1831/12/1731/12/1631/12/1531/12/1431/12/1331/12/1231/12/11
EBITDA -24.133-25.203-5.973-8.971-3.793-2.817-2.585-1.848
Change in Working Capital -0.1095.202-0.7411.332-0.2860.248-0.086-0.055
Cash Taxes Paid --------
Cash Interest Paid/Received --------
Other (incl. non-cash items) --------
Net Cash from Operating Activities -18.111-20.696-5.588-6.353-3.541-2.055-2.526-1.574
Capital Expenditure -0.268-0.217-0.128-0.143-0.221-0.108-0.075-0.028
Acquisitions/Disposals --------
Other Investing Activities --------
Net Cashflow from Investing Activities 5.281-49.469-0.041-0.092-0.196-0.105-0.054-0.025
Dividends --------
Increase/Decrease in Debt --------
Increase/Decrease in Equity 0.00070.03244.7500.00013.1031.8021.0022.139
Other Financing Activities --------
Cash from Financing 0.00063.24641.2030.00013.1031.8021.0152.122
Net increase in cash -12.830-6.91935.574-6.4459.366-0.357-1.5650.523

Directors dealings

Date Director Trans Amount Type Price(p) Value (£) Holding %
- Dr. Sven Jan-Anders Karlsson - - Incentives - - 91684710.00
2019-03-08 Dr. David Raymond Ebsworth P 17500.00 Ords 5.00p 57 9975 235387.00 0.2234829
2019-03-06 Dr. David Raymond Ebsworth P 26300.00 Ords 5.00p 56.3 14807 217887.00 0.2068679
2019-03-04 Dr. David Raymond Ebsworth P 43800.00 Ords 5.00p 57 24966 147787.00 0.1403130
- Vikas Sinha - - Ords 5.00p - - 22222.00 0.0210982
- Dr. Sven Jan-Anders Karlsson - - Ords 5.00p - - 193545.00 0.1837569
2018-09-25 Dr. Sven Jan-Anders Karlsson T 101145.00 ORD 0.1P 0 0 193545.00 0.1837569
2018-08-16 Dr. David Raymond Ebsworth P 12000.00 ORD 0.1P 120 14400 147787.00 0.1403130
- Vikas Sinha - - Incentives - - 120384.00
- Vikas Sinha - - ORD 0.1P - - 22222.00 0.0210982
- Dr. David Raymond Ebsworth - - ORD 0.1P - - 135787.00 0.1292995
- Dr. Sven Jan-Anders Karlsson - - Incentives - - 90391342.00
- Vikas Sinha - - Incentives - - 120384.00
- Dr. Sven Jan-Anders Karlsson - - Incentives - - 89385598.00
2018-03-07 Dr. Sven Jan-Anders Karlsson P 3250.00 ORD 0.1P 145.64 4733 92400.00 0.0877271
2017-11-29 Dr. David Raymond Ebsworth P 10000.00 ORD 0.1P 106.85 10685 135787.00 0.1292995
2017-08-17 Dr. David Raymond Ebsworth P 8130.00 ORD 0.1P 122.5 9959 125787.00 0.1197773
- Vikas Sinha - - Incentives - - 120384.00
- Piers John Morgan - - Incentives - - 802690.00
- Dr. Sven Jan-Anders Karlsson - - Incentives - - 89385598.00
2017-04-27 Vikas Sinha P 177776.00 ORD 0.1P 168.75 299997 177776.00 0.1692824
2017-04-26 Dr. David Raymond Ebsworth P 13373.00 ORD 0.1P 132 17652 117657.00 0.1121781
2017-02-28 Dr. Sven Jan-Anders Karlsson P 12000.00 ORD 0.1P 149 17880 81400.00 0.0775110
2017-03-01 Dr. Sven Jan-Anders Karlsson P 7750.00 ORD 0.1P 149 11548 89150.00 0.0848907
- Dr. Patrick Paul Anthony Humphrey OBE - - Incentives - - 1500000.00
- Dr. Sven Jan-Anders Karlsson - - Incentives - - 88000000.00
- Dr. David Raymond Ebsworth - - 0.1p Ords - - 91995.00 0.1791152
- Dr. Sven Jan-Anders Karlsson - - 0.1p Ords - - 69400.00 0.1351218
2016-08-09 Dr. Sven Jan-Anders Karlsson P 600000.00 0.1p Ords 3.249 19494 3470000.00 0.1351218
- Dr. Sven Jan-Anders Karlsson - - 0.1p Ords - - 2870000.00 0.1118594
- Dr. Sven Jan-Anders Karlsson - - 0.1p Ords - - 2870000.00 0.1118594
2016-01-20 Dr. David Raymond Ebsworth P 400000.00 0.1p Ords 2.5 10000 4599774.00 0.1791152
- Mr. Biresh Roy - - 0.1p Ords - - 900000.00 0.0350460

Dividends

Temporarily not available. Please try again later.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use